Proactive Investors: CytoDyn submits Phase 2 mild-to-moderate coronavirus patient data to the FDA Aug 17, 2020
Proactive Investors: CytoDyn reveals latest mild-to-moderate coronavirus patient data in Phase 2 trial Aug 12, 2020
Proactive Investors: CytoDyn to submit request for pre-submission meetings in U.K. for Leronlimab Aug 7, 2020
Proactive Investors: CytoDyn’s Leronlimab receives positive DSMC recommendation in ongoing Phase 3 study Aug 5, 2020
Spectrum News – LA West: OC Woman Credits Experimental Antibody Drug for COVID-19 Recovery Jul 31, 2020
Proactive Investors: CytoDyn Addresses Negative Claims made by Healthcare Publication STAT on its Coronavirus Study Jul 31, 2020
